Dorsal root ganglion latency and age-driven shingles reactivation
Varicella-zoster virus infects skin, then hides quietly in nerve roots.
Chickenpox spreads via respiratory droplets and skin contact.
VZV replicates in skin, causing the itchy vesicular rash.
Sensory nerve endings in skin pick up virus particles nearby.
Retrograde axonal transport carries virions up to ganglion cell bodies.
Virus reaches dorsal root ganglia within days of the rash appearing.
Neurons rarely divide, so hiding there avoids immune clearance.
Low viral gene expression keeps the virus nearly invisible.
Only a handful of latency-associated transcripts are produced.
A healthy immune system now permanently monitors these ganglia.
This surveillance-latency balance can last a lifetime.
Cell-mediated immunity keeps VZV locked down for most of a lifetime.
The virus is never eliminated, only silenced.
Viral DNA persists as episomes inside neuron nuclei.
VZV-specific CD8+ T-cells continuously patrol ganglia.
Periodic subclinical reactivations get caught and cleared instantly.
Antibodies matter less here — T-cell memory is the real gatekeeper.
Exposure to circulating chickenpox used to "boost" T-cell memory.
Vaccination programs reduced this natural boosting effect.
Aging steadily erodes the T-cell army guarding the ganglia.
Thymic involution slows new T-cell production with age.
Existing VZV-specific clones gradually shrink in number.
Chronic stress, illness, and immunosuppressive drugs speed the decline.
HIV, cancer therapy, and transplants sharply raise risk.
Below a critical T-cell threshold, surveillance can no longer keep pace.
Each subclinical reactivation now clears more slowly.
The balance quietly tips toward the virus.
Weakened surveillance finally lets VZV resume active replication.
Full lytic gene expression restarts inside the neuron.
New virions assemble and begin anterograde transport.
Virions travel along the sensory nerve toward the skin.
This single-dermatome path explains the classic shingles band.
Reactivation stays confined to one nerve root in most cases.
Any surviving T-cells try, and often fail, to intercept the virus.
Virus reaches the skin, producing painful shingles along one dermatome.
Burning pain often precedes the rash by a few days.
Blistering vesicles erupt in a single, band-like dermatome.
Inflammation can leave chronic postherpetic neuralgia.
Risk of lasting pain rises sharply with patient age.
Vaccination remains the most effective way to blunt this outcome.
Antivirals shorten the outbreak if started early.
Restoring T-cell memory through vaccination prevents recurrence.